News | September 23, 2011

Hologic Celebrates Breast Cancer Awareness Month

September 23, 2011 — Hologic Inc. announced that Rob Cascella, company president and CEO, will preside over the NASDAQ stock market opening bell ceremony marking the start of Breast Cancer Awareness Month. The ceremony will begin at 9:15 a.m. (ET) on Oct. 3, 2011.

Breast cancer statistics reveal that:

  • One in eight women in the United States will get breast cancer in their lifetime
  • Breast cancer is the second leading cause of cancer death in the U.S. It is the leading cause of death in women age 35 to 65.
  • Between 1990 and 2007, the mortality rate from breast cancer in the United States decreased by 31 percent, principally due to the contribution of mammographic screening and improved therapies.
  • Approximately 2.5 million women with a history of breast cancer living in America are alive today.

In February 2011, Hologic was the first company to obtain U.S. Food and Drug Administration (FDA) approval for 3-D breast tomosynthesis.

In clinical studies, radiologists reading 2-D mammography and 3-D breast tomosynthesis images - compared to 2-D images alone - demonstrated superior clinical performance in specificity. The combined viewing also illustrated the confidence to rule out breast cancer without recalling the patient for further study and improved sensitivity.

In addition to mammography screening, Hologic provides products and technologies to address the entire continuum of screening, definitive diagnosis and therapy. If a suspicious lesion is detected, breast biopsy systems are designed to provide clinicians with easy access with fewer needle insertions.

Should cancer be detected in its early stages, many women are candidates for targeted radiation therapy, a patient-friendly and effective alternative for women that qualify. Hologic's breast magnetic resonance imaging (MRI) solutions are highly sensitive for cancer staging, problem solving, post-treatment surveillance, and other indications. Breast MRI can detect many breast cancers that are often hidden when using standard imaging.

In addition, for every woman making the Promise to Me pledge, Hologic will contribute funds for mammograms and cervical cancer and bone density screening for women that cannot afford the exams.

The NASDAQ stock market opening bell ceremony will be aired live on NASDAQ.com.

For more information: www.hologic.com

Related Content

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...